Tysabri Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials

The 'Wearing Off' Effect of DMT
Condition:   Multiple Sclerosis Interventions:   Other: ocrelizumab;   Other: natalizumab;   Other: ofatumumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2022 Category: Research Source Type: clinical trials

Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)
Condition:   Sickle Cell Disease Interventions:   Drug: Motixafortide;   Drug: Natalizumab;   Procedure: Leukapheresis Sponsors:   Washington University School of Medicine;   BioLineRx, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2022 Category: Research Source Type: clinical trials